Literature DB >> 7580716

Consulting the public about health service priorities.

C Bowie1, A Richardson, W Sykes.   

Abstract

Consulting the public is an important component of commissioning health services. Somerset Health Authority has devised a method of consultation using eight focus groups meeting three times a year. Each group consists of 12 people, and together the groups are demographically representative of Somerset's population. The groups are asked about issues that are concerning the health authority, and their views have influenced health authority decisions. Each group is given some background information before the meeting, together with more information at the meeting. The discussions are tape recorded and analysed for qualitative information, but the groups are also asked to score certain priorities. The groups have been found to be representative, valid, and focused on community rather than individual values. Health authorities wanting to know the values people attach to health services should adopt this qualitative approach to consultation.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health; National Health Service

Mesh:

Year:  1995        PMID: 7580716      PMCID: PMC2551064          DOI: 10.1136/bmj.311.7013.1155

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  4 in total

1.  Local voices. The bankruptcy of the democratic process.

Authors:  A M Pollock
Journal:  BMJ       Date:  1992-09-05

2.  Prioritising health services in an era of limits: the Oregon experience.

Authors:  J A Kitzhaber
Journal:  BMJ       Date:  1993-08-07

3.  Priority setting in the NHS: reports from six districts.

Authors:  C Ham
Journal:  BMJ       Date:  1993-08-14

4.  Listening to local voices: adapting rapid appraisal to assess health and social needs in general practice.

Authors:  S A Murray; J Tapson; L Turnbull; J McCallum; A Little
Journal:  BMJ       Date:  1994-03-12
  4 in total
  20 in total

1.  The modern doctor's dilemma: rationing and ethics in healthcare.

Authors:  J Butler
Journal:  J R Soc Med       Date:  1999-08       Impact factor: 5.344

2.  Public participation and the moral quality of healthcare rationing.

Authors:  L Doyal
Journal:  Qual Health Care       Date:  1998-06

Review 3.  Eliciting reasons: empirical methods in priority setting.

Authors:  Andreas Hasman
Journal:  Health Care Anal       Date:  2003-03

Review 4.  Resource allocation, social values and the QALY: a review of the debate and empirical evidence.

Authors:  David L B Schwappach
Journal:  Health Expect       Date:  2002-09       Impact factor: 3.377

5.  Alternative interpretations of the same data: flaws in the process of consulting the Canadian public about xenotransplantation issues.

Authors:  James R Wright
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

6.  [What lines of action should the Valencia Society of Family and Community Medicine adopt over the next 4 years?].

Authors:  J C Camposa; A Bonet; F Brotons; D Orozco; V Pedrera; J San Félix; J Joaquín Mira; A García; I Blaya
Journal:  Aten Primaria       Date:  2001-06-30       Impact factor: 1.137

7.  Community involvement in developing policies for genetic testing: assessing the interests and experiences of individuals affected by genetic conditions.

Authors:  Sarah E Gollust; Kira Apse; Barbara P Fuller; Paul Steven Miller; Barbara B Biesecker
Journal:  Am J Public Health       Date:  2005-01       Impact factor: 9.308

Review 8.  Citizen deliberation in setting health-care priorities.

Authors:  Norma Jean Murphy
Journal:  Health Expect       Date:  2005-06       Impact factor: 3.377

9.  Rationing: a transatlantic perspective.

Authors:  S Purdy
Journal:  Br J Gen Pract       Date:  1996-09       Impact factor: 5.386

10.  Assessing Patient Participation in Health Policy Decision-Making in Cyprus.

Authors:  Kyriakos Souliotis; Eirini Agapidaki; Lily Evangelia Peppou; Chara Tzavara; George Samoutis; Mamas Theodorou
Journal:  Int J Health Policy Manag       Date:  2016-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.